Sellas Life Sciences Shares Rise Ahead of Earnings and Regal Results

Sellas Life Sciences shares rose nearly 1% overnight as retail traders anticipated Regal trial results and quarterly earnings. Analysts forecast a smaller loss per share than a year earlier.